Last updated on October 2018

A Long-Term Registry of Humira (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC)


Brief description of study

This is a registry study to evaluate the long-term safety and effectiveness of adalimumab in patients with moderately to severely active UC who are treated as recommended in the product label.

Clinical Study Identifier: NCT01848561

Contact Investigators or Research Sites near you

Start Over

ABBVIE CALL CENTER

Kingston Hosp NHS Foundation /ID# 164109
Kingston upon Thames, United Kingdom
0.77miles
  Connect »

ABBVIE CALL CENTER

Imperial College Healthcare /ID# 145916
London, United Kingdom
9.12miles
  Connect »

ABBVIE CALL CENTER

King's College Hospital NHS /ID# 145698
London, United Kingdom
9.77miles
  Connect »